PRE Company Profile and Key Details

Short-term trend indicators are bearishly aligned (SMA20 -7.63%, SMA50 0.58%, SMA200 45.06%). The stock’s 14-day RSI is 47.45 (neutral), while the ATR of 1.75 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -22.09% below its high and over 475.49% above its low. Average 10-day trading volume of 189.15 thousand shares is below the 3-month average of 222.87 thousand, indicating normal recent market interest.

Prenetics Global Limited generated EPS of -$4.11 over the past year. Five-year average earnings growth is 27.19%. The latest quarter delivered EPS of -$0.53. The next quarter is forecast at -$0.61. Next year's EPS is expected at $86.52. Analyst sentiment is bullish. Analyst rating data shows there are 1 Strong Buy ratings, 4 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $40.00 to $29.00. The high target offers 65.36% upside. The low target suggests 19.88% downside. The mean target is $34.20. This offers 41.38% upside. Prenetics Global Limited earnings surprise history is a mixed track record. The quarter that ended August 18, 2026, missed forecasts by -16.54%. The prior quarter beat by 14.29%. Over the last six quarters, Apple has recorded several small beats. These include 15.49% in September 12, 2025.

Prenetics Global Limited has 15.20 million shares outstanding. The public float is 12.86 million shares, elevated short interest at 4.51% of float. This equals 654.75 thousand shares. The short ratio is 2.82 days. Institutional investors hold 14.95% of the float. Insiders own 14.16%. Yeung Danny Sheng Wu holds 101.24 thousand shares, Clarke Emmanuel has 39.40 thousand shares and Desmet Laurie has 38.39 thousand shares. Over the past six months, insider transactions show net buying. They sold 0.00 shares across 0 transactions.

Prenetics Global Limited last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$18.54. This means the shares are trading below this model’s fair value.

The stock is currently mid-range between its 52-week high and low $11.37 and $27.24. With a market capitalization of about $411.24 million, Prenetics Global Limited is classified as a small-cap and shows lower-than-market volatility (beta ~0.25). Key stats such as the average daily volume over the past year has been around 223.11 thousand shares, volume is running light vs its 52-week average. Headquartered in Hong Kong, None, Prenetics Global Limited operates in the Consumer Defensive sector and the Household & Personal Products industry. Led by CEO Sheng Wu Yeung, the company employs approximately 98 people and listed since July 16, 2021. Prenetics Global Limited is a consumer health sciences company that has pivoted to focus on a consumer health and longevity platform.

Prenetics Global Limited trades at a P/E ratio of -5.81, slightly below the S&P 500 average, with a price-to-sales ratio of 2.88 and a price-to-book ratio of 4.49 trading at moderately above to book value. The P/FCF stands at -12.04, also below market averages.

Prenetics Global Limited (NASDAQ:PRE) shares are flat 3.05% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Prenetics Global Limited trading at a premium to the broader market with a P/E of -5.81. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $19.09, suggesting -21.08% downside. Our AI forecast model points to short-term strength (10.87% over two weeks), a medium-term rise (30.05% over three months), and a longer-term gain (18.89% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Prenetics Global Limited stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 10.87%, with price expected at $26.82 by October 02, 2026, within a range of $24.38 to $29.15 3-Month Outlook: Projected rise of 30.05%, reaching $31.46 by December 17, 2026, with a range of $30.63 to $32.50. 1-Year Outlook: Projected gain of 18.89%, with price at $28.76 by September 17, 2027, within a range of $27.12 to $30.30.